Back to Search Start Over

Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes

Authors :
Ko Willems van Dijk
Nordin M J Hanssen
Jean L.J.M. Scheijen
Hanno Pijl
Mirjam A. Lips
Casper G. Schalkwijk
Dionne E. Maessen
Coen D.A. Stehouwer
Promovendi CD
MUMC+: MA Med Staf Artsass Interne Geneeskunde (9)
Interne Geneeskunde
MUMC+: MA Alg Interne Geneeskunde (9)
MUMC+: HVC Pieken Maastricht Studie (9)
RS: CARIM - R3.01 - Vascular complications of diabetes and the metabolic syndrome
MUMC+: MA Interne Geneeskunde (3)
Source :
Diabetologia, Diabetologia, 59(9), 2013-2017. SPRINGER, Diabetologia, 59(9), 2013-2017. Springer, Cham
Publication Year :
2016
Publisher :
Springer Berlin Heidelberg, 2016.

Abstract

Aims/hypothesis Dicarbonyl compounds are formed as byproducts of glycolysis and are key mediators of diabetic complications. However, evidence of postprandial α-dicarbonyl formation in humans is lacking, and interventions to reduce α-dicarbonyls have not yet been investigated. Therefore, we investigated postprandial α-dicarbonyl levels in obese women without and with type 2 diabetes. Furthermore, we evaluated whether a diet very low in energy (very low calorie diet [VLCD]) or Roux-en-Y gastric bypass (RYGB) reduces α-dicarbonyl stress in obese women with type 2 diabetes. Methods In lean (n = 12) and obese women without (n = 27) or with type 2 diabetes (n = 27), we measured the α-dicarbonyls, methylglyoxal (MGO), glyoxal (GO) and 3-deoxyglucosone (3-DG), and glucose in fasting and postprandial plasma samples obtained during a mixed meal test. Obese women with type 2 diabetes underwent either a VLCD or RYGB. Three weeks after the intervention, individuals underwent a second mixed meal test. Results Obese women with type 2 diabetes had higher fasting and particularly higher postprandial plasma α-dicarbonyl levels, compared with those without diabetes. After three weeks of a VLCD, postprandial α-dicarbonyl levels in diabetic women were significantly reduced (AUC MGO −14%, GO −16%, 3-DG −25%), mainly through reduction of fasting plasma α-dicarbonyls (MGO −13%, GO −13%, 3-DG −33%). Similar results were found after RYGB. Conclusions/interpretation This study shows that type 2 diabetes is characterised by increased fasting and postprandial plasma α-dicarbonyl stress, which can be reduced by improving glucose metabolism through a VLCD or RYGB. These data highlight the potential to reduce reactive α-dicarbonyls in obese individuals with type 2 diabetes. Trial registration: ClinicalTrials.gov NCT01167959 Electronic supplementary material The online version of this article (doi:10.1007/s00125-016-4009-1) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

Details

Language :
English
ISSN :
14320428 and 0012186X
Volume :
59
Database :
OpenAIRE
Journal :
Diabetologia
Accession number :
edsair.doi.dedup.....30efce5bb082ec4c157c2862a3233667